JP Morgan Chase
ORKA

JP Morgan Chase’s Oruka Therapeutics ORKA Stock Holding History

JP Morgan Chase’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.7M Buy
655,027
+632,407
+2,796% +$42.1M ﹤0.01% 1337
2026
Q1 		$1.03M Buy
22,620
+2,203
+11% +$76.6K ﹤0.01% 4591
2025
Q4 		$619K Buy
20,417
+5,938
+41% +$165K ﹤0.01% 4888
2025
Q3 		$278K Sell
14,479
-946
-6% -$14K ﹤0.01% 5337
2025
Q2 		$173K Buy
15,425
+13,115
+568% +$137K ﹤0.01% 5308
2025
Q1 		$23.7K Sell
2,310
-490
-18% -$6.11K ﹤0.01% 6104
2024
Q4 		$54.3K Buy
+2,800
New +$68.3K ﹤0.01% 5986
2024
Q3 		– Sell
-1
Closed -$61 – 7747
2024
Q2 		$61 Sell
1
-1
-50% -$40 ﹤0.01% 6987
2024
Q1 		$32 Buy
2
+1
+100% +$20 ﹤0.01% 7109
2023
Q4 		$27 Hold
1
– – ﹤0.01% 7296
2023
Q3 		$24 Buy
+1
New +$24 ﹤0.01% 7139
2022
Q2 		– Sell
-56
Closed -$2K – 6958
2022
Q1 		$2K Buy
+56
New +$1.39K ﹤0.01% 6445
2021
Q3 		– Sell
-11
Closed – – 6872
2021
Q2 		$0 Buy
+11
New +$459 ﹤0.01% 6664
2020
Q1 		– Sell
-807
Closed -$55K – 5799
2019
Q4 		$55K Buy
+807
New +$51.7K ﹤0.01% 5098

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

JP Morgan Chase's ORKA Position: Q2 2026 in Review

JP Morgan Chase increased its Oruka Therapeutics (ORKA) stake by 2,796% in Q2 2026, buying an estimated $42.1M and bringing the position to 655,027 shares worth $60.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1337.

JP Morgan Chase first reported a position in ORKA in Q4 2019 and has held it in 14 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • JP Morgan Chase held 655,027 shares of Oruka Therapeutics worth $60.7M as of Q2 2026.
  • JP Morgan Chase bought 632,407 Oruka Therapeutics shares in Q2 2026, an estimated $42.1M.
  • Oruka Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1337 holding.
  • JP Morgan Chase first reported a position in Oruka Therapeutics in Q4 2019 and has held it in 14 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.